Lawrence Steinman - 12 Jul 2025 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Reporting relationship: Director
Issuer ticker: ATNF
Reported as of: 12 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jul 2025, 18:56:28 UTC
Prior SEC filing: 18 Jun 2025
Next SEC filing: 27 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Lawrence Steinman

Key filing fact

Lawrence Steinman filed Form 4 for 180 Life Sciences Corp. (ATNF) on 14 Jul 2025.

Key facts

This page summarizes Lawrence Steinman's Form 4 filing for 180 Life Sciences Corp. (ATNF).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Jul 2025, 18:56.

Change

Previous filing in this sequence was filed on 18 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001132679 Primary reporting owner

STEINMAN LAWRENCE

Relationship: Director
Address: 3000 EL CAMINO REAL, BLDG. 4,, SUITE 200, PALO ALTO
Signature: /s/ Lawrence Steinman
Signature date: 14 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATNF holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 112,493
Date: 12 Jul 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATNF holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 110,000
Date: 12 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 110,000
Exercise price: $0.9290
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

As originally reported in the Reporting Person's Form 4/A filed with the SEC on June 30, 2025, the options were to vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. On July 12, 2025, the Board of Directors of the Company, with the recommendation of the Compensation Committee of the Board of Directors, approved the accelerated vesting of all the options effective as of such date. The options are subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for the Company's 2025 Option Incentive Plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained.